ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona

Erasmus MC at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

Erasmus MC takes part in 18 sessions at ESMO 2026 in Madrid. Its program spans treatment and care across several cancers, with particular attention to gastrointestinal and thoracic cancers. Specific topics include whether some patients with oesophageal cancer can avoid surgery after chemoradiotherapy and ways to detect lung nodules using artificial intelligence.

OrganizationESMO 2026 Attendance
Erasmus MC
Rotterdam, Netherlands
Cancer centre & hospital
University medical centre in Rotterdam, Netherlands, with a dedicated cancer institute.
Abstract
Fri Oct 23
13:40–13:50
Chair
Sat Oct 24
08:30–09:15
Poster
Sat Oct 24
12:00–12:45
Chair
Sat Oct 24
14:45–16:15
Updates on rare thoracic tumours
with Medical University of Gdansk
Lung & thoracic cancers
Talk
Sat Oct 24
15:25–15:45
Neuroendocrine tumours beyond SCLC
Updates on rare thoracic tumours
Lung & thoracic cancers
Poster
Sun Oct 25
12:00–12:45
Poster
Sun Oct 25
12:00–12:45
Poster
Sun Oct 25
12:00–12:45
Plasma ctDNA methylation haplotype profiling as a predictive biomarker for FOLFIRINOX response in pancreatic ductal adenocarcinoma
Sunday Poster Display session 3
Gastrointestinal cancersBiomarkers & precision oncology
Talk
Sun Oct 25
15:25–15:45
Best treatment for operable and borderline operable PDAC, including non metastatic biliary tract cancer
State-of-the-art treatment for non metastatic upper GI cancers
Gastrointestinal cancers
Abstract
Mon Oct 26
10:25–10:35
Invited Discussant 3837RO and 3816RO
Rapid oral: Non-metastatic NSCLC and other thoracic malignancies
Lung & thoracic cancers
Talk
Mon Oct 26
10:40–11:00
Dealing with oligoprogression
Optimal management of high-grade serous ovarian cancer with BRCA mutation
Gynaecological cancers
Chair
Mon Oct 26
14:45–16:15
Proffered paper: Non-metastatic NSCLC and other thoracic malignancies
with Gustave Roussy
Lung & thoracic cancers
Talk
Mon Oct 26
16:30–16:50
The pathologist guidance in clinical decision-making in early stage NSCLC
Resectable early stage NSCLC
Lung & thoracic cancers
Satellite
Mon Oct 26
19:30–19:45
Real-world clinical experience with I-O in ES-SCLC
Accord Healthcare - Navigating immunotherapy options in first-line ES-SCLC and NSCLC
Lung & thoracic cancers

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Erasmus MC

Tell us what you sell and we’ll find the people at Erasmus MC most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction